| Autor: |
Itamar, Loewenstein, Aviram, Hochstadt, Ilan, Merdler, Ehud, Chorin, Atalia, Wenkert, Yonatan, Moshkovits, Jonathan, Erez, Ella, Toledano, Yaron, Arbel, Amir, Halkin, Jeremy, Ben-Shoshan, Ariel, Finkelstein, Shmuel, Banai, Maayan, Konigstein |
| Rok vydání: |
2022 |
| Předmět: |
|
| Zdroj: |
Coronary Artery Disease. 33:354-361 |
| ISSN: |
0954-6928 |
| DOI: |
10.1097/mca.0000000000001143 |
| Popis: |
Implantation of drug eluting stents (DES) is the mainstay treatment for patients requiring percutaneous coronary intervention (PCI). The polymer coating of DES has been associated with inflammatory response, increased arterial injury and long-term in-stent restenosis and thrombosis. Polymer-free stents (PFS) were designed to overcome limitations of polymer-coated stents (PCS). Our aim was to compare clinical outcomes of patients undergoing PCI with PFS versus contemporary PCS.This is a prospective, open-label registry study enrolling consecutive all-comers patients admitted to a single center and undergoing PCI using contemporary DES. Clinical outcomes were compared between patients treated with PFS and PCS. The primary endpoint was target lesion revascularization (TLR) at 12 months. Subgroup analyses were conducted for diabetic and nondiabetic patients.Overall, 1664 patients were included: 928 (55.8%) of which were treated with PFS and 736 (44.2%) with PCS for 2046 and 1462 lesions, respectively. At 12 months, TLR rates were not significantly different between the groups (1.7% vs. 2.3% for PFS and PCS, respectively, P = 0.48). The use of PFS did not improve clinical outcomes among diabetic patients in comparison with PCS. Target vessel revascularization and major adverse cardiac events rates were also similar between groups, regardless of diabetes status.Newer generation DES offer excellent results in diabetic and nondiabetic patients without significant differences in outcomes between PCS and PFS. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
